Sava Infond’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Sell
3,930
-140
-3% -$67.2K 0.14% 84
2026
Q1
$2M Sell
4,070
-670
-14% -$364K 0.28% 75
2025
Q4
$2.75M Sell
4,740
-650
-12% -$368K 0.37% 54
2025
Q3
$2.61M Buy
5,390
+1,000
+23% +$465K 0.37% 54
2025
Q2
$1.78M Buy
4,390
+1,430
+48% +$598K 0.28% 70
2025
Q1
$1.47M Hold
2,960
0.28% 77
2024
Q4
$1.54M Buy
+2,960
New +$1.63M 0.27% 70

Other funds holding TMO

Sava Infond's TMO Position: Q2 2026 in Review

Sava Infond reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q2 2026, selling an estimated $67.2K and leaving 3,930 shares worth $1.97M. The position accounts for 0.14% of the portfolio, ranked #84.

Sava Infond first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.75M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sava Infond held 3,930 shares of Thermo Fisher Scientific worth $1.97M as of Q2 2026.
  • Sava Infond sold 140 Thermo Fisher Scientific shares in Q2 2026, an estimated $67.2K.
  • Thermo Fisher Scientific made up 0.14% of Sava Infond's portfolio in Q2 2026, its #84 holding.
  • Sava Infond first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Thermo Fisher Scientific position peaked at $2.75M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.